| Literature DB >> 374761 |
S D Codish, J S Tobias, M Hannigan.
Abstract
The incidence of aspergillosis is increasing while the prognosis remains dismal. Standard single-drug therapy with amphotericin B offers unacceptably low cure rates. A patient with Aspergillus pneumonia was treated with a synergistic combination of amphotericin B and flucytosine. A prompt clinical response and progressive resolution of the infection were observed. Combination therapy appeared to decrease the dose of amphotericin B needed for effective therapy. It may provide improved results with decreased toxic effects.Entities:
Mesh:
Substances:
Year: 1979 PMID: 374761
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272